Correlation Between Equillium and Mirum Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Equillium and Mirum Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Mirum Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Equillium and Mirum Pharmaceuticals, you can compare the effects of market volatilities on Equillium and Mirum Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Mirum Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Mirum Pharmaceuticals.

Diversification Opportunities for Equillium and Mirum Pharmaceuticals

-0.57

Correlation Coefficient

Equillium  Mirum Pharmaceuticals

Excellent diversification

The 3 months correlation between Equillium and Mirum is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Mirum Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mirum Pharmaceuticals and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Mirum Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mirum Pharmaceuticals has no effect on the direction of Equillium i.e., Equillium and Mirum Pharmaceuticals go up and down completely randomly.

Pair Corralation between Equillium and Mirum Pharmaceuticals

Allowing for the 90-day total investment horizon Equillium is expected to under-perform the Mirum Pharmaceuticals. In addition to that, Equillium is 3.23 times more volatile than Mirum Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Mirum Pharmaceuticals is currently generating about 0.06 per unit of volatility. If you would invest  4,113  in Mirum Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of  297.00  from holding Mirum Pharmaceuticals or generate 7.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Equillium  vs.  Mirum Pharmaceuticals

Equillium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Mirum Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Mirum Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Mirum Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Equillium and Mirum Pharmaceuticals

The main advantage of trading using opposite Equillium and Mirum Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Mirum Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mirum Pharmaceuticals will offset losses from the drop in Mirum Pharmaceuticals' long position.

The idea behind Equillium and Mirum Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.